Resmed Inc DRC Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: April 30, 2026 results vs estimates
Resmed Inc DRC Forecast
Resmed Inc DRC short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is positive (6 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 30.9% a year, a typical one-standard-deviation range is 33.90–36.98 over a week, 32.28–38.60 over a month and 24.48–46.40 over a year. (Signals as of 21 Nov 2026.)
Resmed Inc DRC Price Chart
Resmed Inc DRC Factors
Research on Resmed Inc DRC
Explore MacroFinance macro & markets research and analysis.
Resmed Inc DRC Trading Strategies
31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Resmed Inc DRC; 22 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in EFA | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Offensive | Aggressive | Monthly | Premium · upgrade to view | |||
| Momentum Turning Points | Conservative | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Offensive | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's All-Weather Quad Momentum | Aggressive | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Livingston's Mama Bear (Muscular Portfolios) | Aggressive | Monthly | Premium · upgrade to view | |||
| Meb Faber's Global Tactical Asset Allocation 13 (GTAA 13) | Conservative | Monthly | Premium · upgrade to view | |||
| David Varadi's Minimum Correlation Portfolio | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Resmed Inc DRC’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Resmed Inc DRC (Australia)
Resmed Inc DRC is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on ResMed Inc
Frequently asked questions
What is Resmed Inc DRC?
What is the latest Resmed Inc DRC price?
Is Resmed Inc DRC in an uptrend?
How volatile is Resmed Inc DRC?
What factors affect Resmed Inc DRC?
Which trading strategies trade Resmed Inc DRC?
How are Resmed Inc DRC returns analysed?
Where can I download free Resmed Inc DRC historical data?
Free Resmed Inc DRC historical data (last 10 years)
Browse or instantly download the last 10 years of Resmed Inc DRC daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RMD.AU&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 35.44 |
| 2026-11-19 | 36.41 |
| 2026-11-18 | 35.5 |
| 2026-11-17 | 35.59 |
| 2026-11-16 | 35.2 |
| 2026-11-13 | 34.96 |
| 2026-11-12 | 34.47 |
| 2026-11-11 | 33.87 |
| 2026-11-10 | 34.064 |
| 2026-11-09 | 34.2037 |
About this stock
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.